| ALNY |
Alnylam Pharmaceuticals, Inc. |
35.78B |
7.43% |
|
|
|
|
|
277.43 |
1.91% |
41.53% |
23.95% |
|---|
| RNA |
Avidity Biosciences, Inc. |
5.47B |
5.90% |
|
|
|
|
|
46.72 |
-1.66% |
56.64% |
17.35% |
|---|
| NTRA |
Natera, Inc. |
16.59B |
5.12% |
|
|
|
|
|
134.11 |
2.85% |
59.86% |
43.75% |
|---|
| BNTX |
BioNTech SE |
26.30B |
4.86% |
|
|
|
|
|
110.64 |
2.56% |
42.34% |
44.06% |
|---|
| VCYT |
Veracyte, Inc. |
2.80B |
4.71% |
|
|
|
|
|
36.48 |
-2.30% |
114.33% |
45.82% |
|---|
| RARE |
Ultragenyx Pharmaceutical Inc. |
4.64B |
4.48% |
|
|
|
|
|
50.36 |
-0.14% |
37.08% |
14.51% |
|---|
| ILMN |
Illumina, Inc. |
24.07B |
4.46% |
|
|
|
|
|
151.09 |
-2.62% |
32.26% |
2.94% |
|---|
| TECH |
Bio-Techne Corporation |
12.05B |
4.19% |
|
|
|
|
|
75.96 |
-0.50% |
27.89% |
24.26% |
|---|
| SRPT |
Sarepta Therapeutics, Inc. |
11.60B |
3.94% |
|
|
|
|
|
121.61 |
0.99% |
37.13% |
2.20% |
|---|
| QGEN |
Qiagen N.V. |
9.71B |
3.78% |
|
|
|
|
|
43.76 |
-0.88% |
34.79% |
57.43% |
|---|
| LEGN |
Legend Biotech Corporation |
7.33B |
3.78% |
|
|
|
|
|
40.03 |
-2.25% |
66.49% |
50.06% |
|---|
| A |
Agilent Technologies, Inc. |
39.27B |
3.59% |
|
|
|
|
|
136.68 |
-2.11% |
37.68% |
61.37% |
|---|
| MYGN |
Myriad Genetics, Inc. |
1.58B |
3.55% |
|
|
|
|
|
17.41 |
-1.47% |
68.77% |
57.13% |
|---|
| CRSP |
CRISPR Therapeutics AG |
4.41B |
3.31% |
|
|
|
|
|
51.62 |
-0.50% |
45.89% |
-6.27% |
|---|
| ARWR |
Arrowhead Pharmaceuticals, Inc. |
2.72B |
3.22% |
|
|
|
|
|
21.89 |
2.34% |
62.96% |
54.99% |
|---|
| 1548.HK |
GENSCRIPT BIOTECH CORP |
|
3.12% |
|
|
|
|
|
|
|
|
|
|---|
| BMRN |
BioMarin Pharmaceutical Inc. |
12.78B |
2.88% |
|
|
|
|
|
67.07 |
0.19% |
27.49% |
16.33% |
|---|
| BEAM |
Beam Therapeutics Inc. |
2.23B |
2.79% |
|
|
|
|
|
27.06 |
3.68% |
90.14% |
73.87% |
|---|
| RCKT |
Rocket Pharmaceuticals, Inc. |
1.59B |
2.70% |
|
|
|
|
|
17.45 |
1.16% |
81.66% |
66.67% |
|---|
| NTLA |
Intellia Therapeutics, Inc. |
1.70B |
2.62% |
|
|
|
|
|
16.73 |
4.56% |
97.64% |
78.36% |
|---|
| GILD |
Gilead Sciences, Inc. |
120.22B |
2.47% |
|
|
|
|
|
96.57 |
-1.36% |
19.01% |
2.01% |
|---|
| VRTX |
Vertex Pharmaceuticals Incorporated |
133.37B |
2.19% |
|
|
|
|
|
516.74 |
2.84% |
31.79% |
69.89% |
|---|
| TXG |
10x Genomics, Inc. |
1.89B |
2.16% |
|
|
|
|
|
15.64 |
-3.28% |
47.99% |
26.61% |
|---|
| CDNA |
CareDx, Inc |
1.25B |
2.06% |
|
|
|
|
|
23.65 |
-0.96% |
127.36% |
37.09% |
|---|
| MRNA |
Moderna, Inc. |
18.00B |
1.90% |
|
|
|
|
|
46.83 |
-6.86% |
64.88% |
57.96% |
|---|
| VIR |
Vir Biotechnology, Inc. |
1.31B |
1.26% |
|
|
|
|
|
9.60 |
-1.74% |
85.23% |
77.08% |
|---|
| PACB |
Pacific Biosciences of California, Inc. |
626.82M |
0.98% |
|
|
|
|
|
2.3000 |
-6.12% |
123.18% |
49.18% |
|---|
| SANA |
Sana Biotechnology, Inc. |
668.51M |
0.84% |
|
|
|
|
|
3.01 |
-3.06% |
189.68% |
56.58% |
|---|
| RGNX |
REGENXBIO Inc. |
551.56M |
0.74% |
|
|
|
|
|
11.16 |
-0.27% |
117.99% |
80.35% |
|---|
| FLGT |
Fulgent Genetics, Inc. |
588.66M |
0.74% |
|
|
|
|
|
19.43 |
-11.76% |
44.74% |
41.44% |
|---|
| VERV |
Verve Therapeutics, Inc. |
533.98M |
0.60% |
|
|
|
|
|
6.31 |
-0.79% |
415.07% |
45.14% |
|---|
| 4974.T |
TAKARA BIO INC |
|
0.56% |
|
|
|
|
|
|
|
|
|
|---|
| ALLO |
Allogene Therapeutics, Inc. |
644.06M |
0.54% |
|
|
|
|
|
3.08 |
-3.45% |
266.14% |
52.83% |
|---|
| QURE |
uniQure N.V. |
379.35M |
0.51% |
|
|
|
|
|
7.79 |
4.85% |
68.03% |
54.67% |
|---|
| EDIT |
Editas Medicine, Inc. |
257.33M |
0.46% |
|
|
|
|
|
3.12 |
-1.58% |
189.07% |
91.23% |
|---|
| TSVT |
2seventy bio, Inc. |
243.59M |
0.42% |
|
|
|
|
|
4.73 |
-5.59% |
290.67% |
24.20% |
|---|
| PSTX |
Poseida Therapeutics, Inc. |
299.17M |
0.33% |
|
|
|
|
|
3.08 |
5.12% |
231.07% |
29.94% |
|---|
| CRBU |
Caribou Biosciences, Inc. |
242.17M |
0.28% |
|
|
|
|
|
2.6800 |
-3.60% |
177.76% |
32.83% |
|---|
| LYEL |
Lyell Immunopharma, Inc. |
312.32M |
0.21% |
|
|
|
|
|
1.2200 |
0.00% |
386.53% |
100.00% |
|---|
| BLUE |
bluebird bio, Inc. |
78.67M |
0.17% |
|
|
|
|
|
0.4057 |
6.18% |
476.85% |
46.13% |
|---|
| GRAL |
GRAIL INC |
|
0.07% |
|
|
|
|
|
|
|
|
|
|---|
| E |
Eni S.p.A. |
47.59B |
0.01% |
|
|
|
|
|
29.92 |
-2.06% |
78.58% |
46.77% |
|---|